NMRA
USDNeumora Therapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$2.560
Kõrge
$2.920
Madal
$2.550
Maht
1.60M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
480.9M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
1.36M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Neumora Therapeutics to Participate in Upcoming Conferences in November
WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NASDAQ:NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel
Needham Maintains Buy on Neumora Therapeutics, Raises Price Target to $8
Needham analyst Ami Fadia maintains Neumora Therapeutics with a Buy and raises the price target from $6 to $8.
Guggenheim Upgrades Neumora Therapeutics to Buy, Announces $14 Price Target
Guggenheim analyst Yatin Suneja upgrades Neumora Therapeutics from Neutral to Buy and announces $14 price target.
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model
NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction NMRA-215 demonstrated best-in-class weight loss of up to 26% in combination with semaglutide Class-leading
Seotud aktsiad
QRTEP
Qurate Retail Inc. 8.0% Fixed Rate Cumulative Redeemable Preferred Stock
VKI
Invesco Advantage Municipal Income Trust II Common Shares of Beneficial Interest (DE)
CVV
CVD Equipment Corporation
LUNA
Luna Innovations Incorporated
AFJK
Aimei Health Technology Co. Ltd Ordinary Share
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.